The Safety Evaluation and Surveillance of Generic Drugs

Food and Drug Administration (FDA)

This webinar provides health care professionals with information on the evaluations performed, methods, and tools used by FDA's Office of Generic Drugs (OGD's) Office of Safety and Clinical Evaluation (OSCE) to assess the safety and effectiveness of generic drugs throughout the life-cycle of the product (e.g., pre-market and post-market setting).

Tuesday, November 29
1:00 - 2:30 PM ET

Register HERE